Yan Hu Siying Ren Ruoyao Wang Wei Han Peng Xiao Li Wang Fenglei Yu Wenliang Liu
10.3389/fphar.2022.816683
Front Pharmacol
2022 Jul 6;13:816683.
alk alectinib neoadjuvant therapy non-small cell lung cancer pathological complete response
CC BY
https://pubmed.ncbi.nlm.nih.gov/35873553/
Case Reports
PMC9299059
35873553
Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer
2022